Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.
about
Research gaps in defining the biological link between HIV risk and hormonal contraceptionPartners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV InfectionSystemic cytokine levels show limited correlation with risk of HIV-1 acquisition.Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediatorsMucosal immunity in the female genital tract, HIV/AIDSHIV-1 shedding from the female genital tract is associated with increased Th1 cytokines/chemokines that maintain tissue homeostasis and proportions of CD8+FOXP3+ T cellsMicrobiome in human immunodeficiency virus infection.Representation of women and pregnant women in HIV research: a limited systematic review.Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection.Immune activation in the female genital tract during HIV infection predicts mucosal CD4 depletion and HIV shedding.Twelve-Month Antiretroviral Therapy Suppresses Plasma and Genital Viral Loads but Fails to Alter Genital Levels of Cytokines, in a Cohort of HIV-Infected Rwandan Women.Vaginal Cytomegalovirus Shedding Before and After Initiation of Antiretroviral Therapy in Rakai, Uganda.Effect of trichomoniasis therapy on genital HIV viral burden among African womenA perspective on progress and gaps in HIV prevention scienceGenital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity.Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation.Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal women.Associations between genital tract infections, genital tract inflammation, and cervical cytobrush HIV-1 DNA in US versus Kenyan womenHuman immunodeficiency viruses appear compartmentalized to the female genital tract in cross-sectional analyses but genital lineages do not persist over time.Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women.The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract.Cervical intraepithelial neoplasia is associated with genital tract mucosal inflammation.Barriers to HIV remission research in low- and middle-income countries.The association between HPV, intraepithelial lesions and HIV-1 shedding in anogenital specimens in two contrasting populations: Senegalese women and American MSM.Persistent Mycoplasma genitalium infection of human endocervical epithelial cells elicits chronic inflammatory cytokine secretionEffects of Long-Term Vitamin D Supplementation on Regression and Metabolic Status of Cervical Intraepithelial Neoplasia: a Randomized, Double-Blind, Placebo-Controlled Trial.The favourable effects of long-term selenium supplementation on regression of cervical tissues and metabolic profiles of patients with cervical intraepithelial neoplasia: a randomised, double-blind, placebo-controlled trial.
P2860
Q27002559-132ABDFF-82D6-46B8-84E3-AAD1DE8CC5DBQ28079533-3BBA4142-7DCC-43CE-B170-120A711CA595Q33610963-03028189-42E7-4444-B192-E5B14AD34564Q33999185-A32DC924-258B-4CFE-AB39-80BC3A8D441AQ34275424-B47B9C79-CB1B-49A3-A2E9-B7114233360DQ34422185-7BC02F25-123C-4408-8495-1B8ADB3FE97BQ34626014-052CFCCD-84A4-4CEB-822C-EB2F628C768CQ34979789-B2971B47-034B-4D96-8D65-A2C05218380AQ35252587-304BC28D-B8CE-43E1-91FA-3C702EBB20E7Q35331430-21A6FE5A-BFAF-4958-BFE1-50C44435528BQ35641764-5DF4BF34-1D16-447F-8665-505D413B5231Q35993475-C0356112-46A8-4CD8-9D08-E200C9B29EAFQ36099364-9D1F1FEB-35BB-4976-BB26-48E99AEA4042Q36358897-A9A1207D-FC1B-433B-B15B-A568F46B9A73Q36358905-F6DA34D2-BCA1-49E5-922E-52FC5DEE67EAQ36389094-0D1DEA48-64D3-40F9-AB70-2AE143712FC7Q36430073-D33D80A4-7DC5-439A-9D94-AD18C1615E68Q36545289-589595D8-9BEE-4635-89A6-182FAC66A149Q36702615-3920DA66-C806-4095-8D6D-74C3174140C2Q36837376-A5060C02-6367-41D5-A3EE-612DB1166333Q36996000-1DFC45E3-43F6-4218-8E1E-8120845EB54EQ37210863-11073526-76B4-47B5-AF96-2DFB5A794152Q37693958-36F58DAA-6001-4667-87BA-0445FCC15A96Q39366791-D91B2073-73A0-49A9-AECD-9B26E1896EA0Q41011410-C6D7ADE0-070F-4F38-B21A-51D4523CCC41Q41584983-0C591FDB-BFC0-446C-8A15-DA75121A27B7Q51274280-38D068A2-0710-4250-BC75-E988127D6CF4Q51295994-B97C8250-B9FA-426E-99DB-89B0EE824A0C
P2860
Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Cervicovaginal shedding of HIV ...... changes in vaginal microbiota.
@ast
Cervicovaginal shedding of HIV ...... changes in vaginal microbiota.
@en
Cervicovaginal shedding of HIV ...... changes in vaginal microbiota.
@nl
type
label
Cervicovaginal shedding of HIV ...... changes in vaginal microbiota.
@ast
Cervicovaginal shedding of HIV ...... changes in vaginal microbiota.
@en
Cervicovaginal shedding of HIV ...... changes in vaginal microbiota.
@nl
prefLabel
Cervicovaginal shedding of HIV ...... changes in vaginal microbiota.
@ast
Cervicovaginal shedding of HIV ...... changes in vaginal microbiota.
@en
Cervicovaginal shedding of HIV ...... changes in vaginal microbiota.
@nl
P2093
P2860
P356
P1476
Cervicovaginal shedding of HIV ...... changes in vaginal microbiota.
@en
P2093
Amneris E Luque
Caroline Mitchell
Jane Hitti
Kathleen Paul
Kathy Agnew
Robert Coombs
Susan E Cohn
P2860
P356
10.1089/AID.2010.0129
P577
2010-10-07T00:00:00Z